SEC 13F Intelligence

Managers / Q1 2020 · view latest →

CVI Holdings, LLC

CIK 0001728194 · ONE COMMERCE CENTER, 1201 N. ORANGE STREET, SUITE 715, WILMINGTON, DE, 19801 · 6106172600

Reported Value
$28M
Q1 2020
Positions
37
Filings on Record
25
2019–present window
Filed
May 15, 2020
original filing

Summary

Cvi Holdings, LLC reported $28M in U.S.-listed holdings across 37 positions for Q1 2020.

The portfolio is heavily concentrated: Timkensteel alone accounts for 29.6% of reported value.

Compared with Q4 2019, the fund opened 17 new positions and exited 16.

Portfolio Metrics

Turnover
+33.1%
vs prior filed quarter
Top-10 Concentration
+80.0%
share of reported value
Largest Position
+29.6%
Timkensteel
New / Exited
17 / 16
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $45MQ4 ’18Q1 ’19: $106MQ2 ’19: $172MQ3 ’19: $131MQ3 ’19Q4 ’19: $71MQ1 ’20: $28MQ2 ’20: $270MQ2 ’20Q3 ’20: $246MQ4 ’20: $536MQ1 ’21: $1.4BQ1 ’21Q2 ’21: $1.5BQ3 ’21: $1.6BQ4 ’21: $1.5BQ4 ’21Q1 ’22: $1.5BQ2 ’22: $1.4BQ3 ’22: $1.3BQ3 ’22Q4 ’22: $784MQ1 ’23: $266MQ2 ’23: $95MQ2 ’23Q3 ’23: $51MQ4 ’23: $48MQ1 ’24: $106MQ1 ’24Q2 ’24: $116Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 45.3%Other: 39.0%Common Stock: 15.7%
  • US DOMESTIC · 45.3% · $13M
  • Other · 39.0% · $11M
  • Common Stock · 15.7% · $4M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
YUNHONG INTLNEW+350.0K350.0K+$3M$3M
INOVIO PHARMACEUTICALS INCNEW+2.00M2.00M+$3M$3M
ENLIVEX THERAPEUTICS LTDNEW+385.6K385.6K+$2M$2M
ADAMIS PHARMACEUTICALS CORPNEW+3.40M3.40M+$1M$1M
BAUDAX BIO INCNEW+432.3K432.3K+$1M$1M
CELSION CORPORATIONNEW+1.14M1.14M+$1M$1M
EROS INTL PLCNEW+481.0K481.0K+$794,000$794,000
RXIIEURPHIO PHARMACEUTICALS CORPNEW+360.1K360.1K+$637,000$637,000

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

36 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TIMKENSTEEL CORPNOTE 6.000% 6/029.60%$8M10.46M
2YUNHONG INTLUNIT 99/99/999911.68%$3M350.0K
3INOVIO PHARMACEUTICALS INCNOTE 6.500% 3/010.48%$3M2.00M
4ENLIVEX THERAPEUTICS LTDCOM6.34%$2M385.6K
5SENSEONICS HLDGS INCNOTE 5.250% 2/05.19%$1M1.50M
6ADAMIS PHARMACEUTICALS CORPCOM NEW4.26%$1M3.40M
7BAUDAX BIO INCCOM3.76%$1M432.3K
8CELSION CORPORATIONCOM PAR NEW3.62%$1M1.14M
9EROS INTL PLCSHS NEW2.79%$794,000481.0K
10RXIIEURPHIO PHARMACEUTICALS CORPhistory →COM NEW2.24%$637,000360.1K
11VERASTEM INCCOM2.16%$614,000232.6K
12KITOV PHARMA LTDSPONSORED ADS2.12%$605,0001.98M
13RESNUSDRESONANT INChistory →COM2.11%$600,000405.3K
14REPLREPLIMUNE GROUP INChistory →COM2.05%$584,00058.6K
15COOL1EURPOLARITYTE INChistory →COM1.71%$487,000451.2K
16NOVN1EURNOVAN INChistory →COM1.53%$435,0002.91M
17YB4PSAVARA INChistory →COM1.52%$434,000204.7K
18AMRSEURAMYRIS INChistory →COM NEW1.01%$288,000112.6K
19TTPHEURTETRAPHASE PHARMACEUTICALS ICOM NEW0.93%$266,000208.1K
20VASCULAR BIOGENICS LTDCOM0.86%$246,000181.9K
21FARMMI INCSHS0.80%$229,000426.4K
22BELLEROPHON THERAPEUTICS INCCOM NEW0.74%$210,00019.2K
23MCF1EURCONTANGO OIL & GAS COCOM NEW0.48%$137,00091.1K
24RGLSUSDREGULUS THERAPEUTICS INCCOM NEW0.45%$129,000280.2K
25SOL GEL TECHNOLOGIESSHS0.25%$71,00010.1K
26VERB TECHNOLOGY CO INC*W EXP 03/14/2020.24%$67,000240.0K
27XCUREXICURE INCCOM0.23%$66,00044.8K
28CHECK CAP LTD*W EXP 05/03/2020.08%$23,000136.4K
29SIGMA LABS INC*W EXP 02/15/2020.03%$9,00048.1K
30ARTELO BIOSCIENCES INC*W EXP 06/25/2020.01%$4,00065.0K
31BENITEC BIOPHARMA LTD*W EXP 08/14/2020.01%$2,00050.0K
32PLUS THERAPEUTICS INC*W EXP 05/28/2020.01%$2,000259.2K
33MEDIGUS LTD*W EXP 07/23/2020.00%$1,00063.3K
34CREATIVE REALITIES INC*W EXP 11/09/2020.00%$1,00015.0K
35AMERI HLDGS INC*W EXP 11/08/2020.00%$1,00085.2K
36ENERGY FUELS INC*W EXP 09/20/2020.00%$0277.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$116M144Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$106M157May 7, 202413F-HRchanges · EDGAR ↗
Q4 2023$48M187Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$51M229Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$95M277Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$266M413May 16, 202313F-HRchanges · EDGAR ↗
Q4 2022$784M615Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B882Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B930Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.5B928May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.5B948Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.6B899Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.5B790Aug 11, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.4B615May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$536M182Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$246M83Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$270M70Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$28M37May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$71M36Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019REVEALED$131M107Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019REVEALED$172M118Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$106M58May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$45M42Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 2 additional managers.

  • HEIGHTS CAPITAL MANAGEMENT, INC028-13218
  • CVI Investments, Inc.028-17822

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.